A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 7, Pages 1187-1196
Publisher
Springer Science and Business Media LLC
Online
2021-06-22
DOI
10.1038/s41591-021-01369-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias
- (2020) Jessica Lim et al. Therapeutic Innovation & Regulatory Science
- Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease
- (2020) Samantha Budd Haeberlein et al. Alzheimers & Dementia
- Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers
- (2019) Brian A Gordon et al. BRAIN
- Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
- (2019) David Henley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?
- (2019) Dennis Selkoe LANCET NEUROLOGY
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
- (2018) Brian A Gordon et al. LANCET NEUROLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease
- (2018) Guoqiao Wang et al. STATISTICS IN MEDICINE
- Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
- (2018) Yi Su et al. NeuroImage-Clinical
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
- (2016) Stacie Weninger et al. Alzheimers & Dementia
- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- The amyloid cascade hypothesis: are we poised for success or failure?
- (2016) Eric Karran et al. JOURNAL OF NEUROCHEMISTRY
- Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
- (2016) John M. Ringman et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Drug development in Alzheimer’s disease: the path to 2025
- (2016) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Partial volume correction in quantitative amyloid imaging
- (2015) Yi Su et al. NEUROIMAGE
- Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
- (2014) D. C. Ryman et al. NEUROLOGY
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
- (2014) Jeffrey L Cummings et al. Alzheimers Research & Therapy
- Use of historical control data for assessing treatment effects in clinical trials
- (2013) Kert Viele et al. PHARMACEUTICAL STATISTICS
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
- (2013) S.M. Mills et al. REVUE NEUROLOGIQUE
- Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
- (2013) Krista L Moulder et al. Alzheimers Research & Therapy
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- FreeSurfer
- (2012) Bruce Fischl NEUROIMAGE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitivity and Test-Retest Reliability of the International Shopping List Test in Assessing Verbal Learning and Memory in Mild Alzheimer's Disease
- (2011) T. A. C. Thompson et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
- (2011) Randall J Bateman et al. Alzheimers Research & Therapy
- Variations in the neuropathology of familial Alzheimer’s disease
- (2009) Claire Shepherd et al. ACTA NEUROPATHOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now